acarbose renal failure

Dr Hilary warns about missed dementia diagnoses in July

We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info

According to Alzheimer’s Research UK, one in three people born this year will eventually develop dementia during their life. There are many different types of dementia, with Alzheimer’s disease and vascular dementia being the most prevalent. The new self-administered test may help identify early signs of both of these types as well as others.

The new test able to identify early, subtle signs of dementia was developed by the Ohio State University Wexner Medical Centre, College of Medicine and College of Public Health.

They explain this self-administered test can expose the signs of cognitive decline “sooner” than other tests.

There’s also a new study, published in the journal Alzheimer’s Research & Therapy, flagyl adverse reactions looking into the efficiency of this test.

This study reports that forgetfulness may come hand in hand with ageing, but it can be difficult to tell if this is signalling something more serious.

It adds that this could be revolutionised by the new test, which can be taken “anywhere”.

The new test is called Self-Administered Gerocognitive Examination or SAGE test for short.

It can be found on the Wexner Medical Centre website here. All you need to do is print out the test from the website and get a pen.

There are four different forms of the test, however, it’s sufficient to only take one of those. And it doesn’t matter which one you choose.

It takes about 10 to 15 minutes to fill it out. You can do it anywhere you want, but you can’t ask others for help.

Once you’ve completed the set of questions, you should take the answers to your doctor so they can provide you with the right score. 

The new study linked to the test explains that SAGE is “critical” as it can offer early detection of dementia and consequent treatment.

Dr Douglas Scharre, the lead author of the study, said: “We know that the earlier cognitive impairment is detected, the more treatment choices a patient has and the better the treatments work.”

The study lasted for eight years and looked at 665 participants. During this time, the researchers discovered that the SAGE test “accurately” identified 164 patients with mild cognitive impairment.

Out of these 164 people, 70 converted to dementia. The dementia diagnoses included cases of Alzheimer’s disease, Lewy body dementia and vascular dementia.

The study states this to be a 43 percent conversion rate over the period of three to four years which is similar to rates from other academic centre-based studies.

However, this new test isn’t a definitive diagnosis of dementia.

It merely allows doctors to identify possible early signs of cognitive decline.

The lead author explained this is important as primary care physicians “often” might not be able to recognise subtle cognitive signs during routine check-ups.

The SAGE test looks at cognitive areas, including orientation, language, calculations, memory and others.

Scharre said: “Any time you or your family member notices a change in your brain function or personality you should take this test. 

” “If that person takes the test every six months and their score drops two or three points over a year-and-a-half, that is a significant difference.

“[The] doctor can use that information to get a jump on identifying the causes of the cognitive loss and to make treatment decisions.”

You can download the new test on this website:


Source: Read Full Article